key: cord-0778305-xectb16w authors: Zhou, Fating; Yu, Xiaogang; Tong, Xiaowei; Zhang, Rong title: Clinical features and outcomes of 197 adult discharged patients with COVID-19 in Yichang, Hubei date: 2020-03-30 journal: nan DOI: 10.1101/2020.03.26.20041426 sha: ce0c3e05715871dda6204ee0c52bcc95d2b89b91 doc_id: 778305 cord_uid: xectb16w Purpose To investigate the epidemiology and clinical features of discharged adult patients with COVID-19 in Yichang. Method The retrospective study recruited 197 cases of COVID-19 discharged from Yichang Central People's Hospital and Yichang Third People's Hospital from Jan 17 to Feb 26, 2020. All cases were confirmed by real-time RT-PCR or chest computer tomography (CT).The survivors were followed up until March 4,2020. Clinical data, including demographic characteristic, presentation, exposure history, laboratory examination, radiology and prognosis were enrolled and analyzed by SPSS 19.0 software. Results There were 197 adult discharged patients with COVID-19 in this study. Statistical analysis indicated that the average age was 55.94 years, and female patients were 50.3%. Those patients mainly resided in urban with exposure history in 2 weeks. Fever, cough and weakness were the common symptoms. Leucocytes were mainly normal or decreased in 185 patents, both lymphocytes and eosinophils reduced, the ratios were 56.9% and 50.3%, respectively. On the contrary, lactate dehydrogenases raised in 65 patients. C-reactive protein elevated in the most of patients. The sensitivity of RT-PCR was 63.5%. Chest CT indicated that bilateral patchy shadows were the most common imaging manifestations.169 patients recovered and transferred to a designated hospital for observation, and the others turned worst and died of acute respiratory failure. Conclusion COIVD-19 infection have become a life-threaten public health problem, the sensitivity of RT-PCR was limited. Chest CT scan was recommended for the suspected patients. Moreover, lymphocytopenia and eosinophils declining without leukocytes increasing may be considered as a useful evidence for the diagnosis. Similar to the server acute respiratory syndrome (SARS) and Middle East respiratory (MERS), 2019-nCoV can also cause serve acute respiratory syndrome [3] . Numerous patients can be cured effectively at the early stage, but some patients with COVID-19 may develop pulmonary edema, ARDS, or multiple organ failure, and even died abruptly [4] . Currently, researches about epidemiology and clinical features of COVID-19 focused on the hospitalized patients [5] , but the discharged patients was still scarcely investigate. Therefore, this study was aimed to clarify the epidemiology and clinical features of discharged patients with COVID-19. This study was approved by the Ethics Committee of Yichang Central people's hospital. All adult discharged patients with COVID-19 from Yichang Central People's Hospital and Yichang third People's Hospital from Jan 17 to Feb 26, 2020. Those patients with exposure histories were confirmed by chest CT scans or RT-PCR assays. Throat•swab or broncholveolr lvge fluid sample were collected from all the suspected patients at admission, and RT-PCR assays were performed at clinical laboratory. According to the 5th edition expert conference of Chinese healthy commission, those suspected patients presenting with lung imaging features also regard as clinically diagnosis-cases in Hubei province. ARDS was identified in accordance with the Berlin definition [6] , and acute kidney injury was verified according to Improve Global Outcome definition [7] . If the serum levels of cardiac biomarkers ascended to the 99th percentile upper reference limit or new abnormalities were displayed in echocardiography or electrocardiography (ECG), the patient was regarded as acute cardiac injury. The discharged criteria included that symptom disappeared and the lesions eliminated evidently in the chest CT. Furthermore, RT-PCR was negative continual 2 tests beyond 24 hours. After discharged from hospital, the patients went to the designated hospital for observation. All patients except deaths were monitored up to March 4, 2020. Clinical data, including date, ages, occupation, location, presentation, underlying diseases, laboratory test, RT-PCR ， chest CT, treatment and outcome was collected from electronic medical record(EMR) . If data was missing, we collected by direct communication with attending doctor. Then the data was inputted and analyzed by SPSS 19.0 software. Descriptive statistics were presented as median with interquartile range or frequency with percentage. A total of 197 adult discharged patients with COVID-19 were recruited in Yichang Central People's Hospital(101, 51.3%)and Yichang third people's hospital(86，48.7%).The first cases was a 65-years old woman from Wuhan on January15, 2020. The quantity of admitted patients increased sharply on the 15 days later, ascended to the peak on the February 2, and decreased obviously on Fever (153, 77.6%) was the most common presentations, following cough (89, 45.2%) and weakness (29, 14.7%), respectively. Other less common symptoms were sore throat (11, 5 .6%), shortness of breath (10, 5.1%), and muscle ache (9, 4.6%, Table 2 ). However, 3 patients without any complaints were detected by chest CT scan. Among all those patients, the average days from exposure to symptom onset was 6.14±9.27days. The longest incubation period was 55 days. 48 patients were accompanied with underlaying illness, including cardiovascular (24.4%) and cerebrovascular diseases (4.6%), endocrine system diseases (9.1%), chronic renal disease (1.5%), malignant tumor(1.5%), and digestive system diseases (1.0%), nervous system diseases. Considering vital sign and CT manifestations, 56 patients were admitted to intensive cure unite (ICU), and 141 patients were transferred to general isolation wards. The laboratory examination was underwent after admission, the blood routine results revealed that monocytes and platelet kept at normal range in numerous patients, leukocytes were at the normal range in 117 (59.4%) patients, and below the normal range in 66 (33.5%) patients. While lymphocytes decreased in many patients. Interestingly, eosinophils displayed a similar change tendency as lymphocytes, it decreased obviously over half of them. 44 (22.3%) patients had different degrees of liver function abnormality, with elevating of aspartate aminotransferase (AST) or alanine aminotransferase (ALT). Total bilirubin (TBIL) was above the normal range in 24(12.2%) patients, and direct bilirubin (DBIL) was above in 10 (5.1%) patient. Most of those patients had a abnormal myocardial zymogram, which indicated that creatine kinase was above in 10 (5.1%) patients, creatine kinase MB in 19 (9.6%) patients, and lactate dehydrogenase in 65(33.0%) patients. For the coagulation tests, prothrombin time (PT) and activated partial thromboplastin time (APTT) were at the normal range in the majority of patients, while fibrinogen was above the normal range in the 78 (39.6%) patients. D-dimmer was above the normal range in the 99 (47.2%) patients. 65 (33.0%) patients had different degrees of renal function damage, with elevating blood urea nitrogen or creatinine. Blood gas analysis was examined in 69 cases, and the results demonstrated that PaO 2 was decreased in the 28(40.5%) patients. Regarding the infection index, procalcitonin(PCT) mainly kept at the normal range. On the contrary, c-reative protein (CRP), erythrocyte sedimentation rate (ESR) and interleukin-6 (IL-6) increased in most of patients. Although RT-PCR was regarded the most accurate examinations for COVID-19, the sensitivity was limited. RT-PCR positive rate was 63.5%, the first test was 46.7%, and the second test was 11.2%. Comparing with PCR , almost all patients had been discover lesions in the chest CT scans, 32 (15.3%) patients displayed unilateral pneumonia, 136 (69.0%)patients displayed bilateral pneumonia, and only 25(12.7%) patients displayed multiple mottling and ground-glass opacity(Table 4, Figure 2 ). injury and ARDS. Most patients were treated with antiviral drugs (Oseltamivir), 151(76.6%) patients received antibiotics(moxifloxacin and cefperazone-sulbactam), and several patients were treated with glucocorticoids (75, 38.1%) and immunoglobulin(52, 26.9%). Additionally, 81(41.1%) patients were treated with Chinese traditional medicine. By the end of Febururay 26, 28 (14.2%) patients had died, and 169(85.2%) patient was discharged and transferred to designated hospital for observation. The average of hospital stay was 15.08 days (Table 4 ). Coronavirus was a large RNA virus, including SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-229E, HCoV-NL63 and HCoV-HKU1. SARS-CoV and MERS-CoV may induce sever respiratory syndrome, but the remains only caused mild upper respiratory infectious.2019-nCoV was a new subtype, with high incidence and rapid infection, it has spread widely in China and abroad, involving Italy, German, Korean, Iran, and Japan [8] [9] . At present, there was no vaccine and antiviral drugs against this disease. Therefore, Extensive studies of clinical features on COVID-19 have not only a better understanding of coronavirus transmission,but have also been key to detect quickly and accurately. COVID-19 diagnosis was based on exposure histories, symptoms, laboratory tests, chest CT and RT-PCR. In the early phase of the epidemic, almost all patients worked at or lived around the Huanan Seafood Whole Market in Wuhan [10] . With COVID-19 spread rapidly in Hubei province, Wuhan-related exposures was regarded as a key criterion. Previous retrospective research demonstrated that 86% cases had a Wuhan-related exposures history [11] . Similarly, our study revealed most of infected patients lived around Xiling strict, because of many residents working at China Gezhouba Group Corporation, returning from Wuhan. The common symptoms of COVID-19 patients were fever, fatigue and cough, some patients may present with abdominal symptoms [12] . While a few patients without any symptoms were detected accidentally by chest CT [11] .Thus, it is difficult to suspect the disease without auxiliary examinations. The significant of laboratory examinations was blood routine, the results suggested leukocytes were mainly normal or decreased, and lymphocytes reduced evidently in many COVID-19 patients [13] . A recent research indicated that lymphocytes,especially CD3 + lymphocytes and CD45 + lymphocytes, decreased significantly in comparison with non-COVID patients, while there was no significantly difference in quantities and proportions of neutrophils and monocytes [14] .Results of this analysis showed lymphocytes and eostinophils decreased obviously without leukocytes increasing in most patients, and neutrophils,monocytes and platelet mainly kept at normal range,it was consistent with previous reports. In term of chest CT, the typical image features were peripheral, subpleural ground glass opacities in the lower lobes. However, a study of CT manifestations demonstrated that it was approximately 14% COVID-19 patients with atypical CT features [15] . Real time RT-PCR was considered a standard assessment for COVID-19，but the sensitivity was lower than chest CT scans, RT-PCR was 71%, chest CT scans reached 98% [16] .Thus, it was essential to perform chest CT for detecting the suspected patients. As described before, there was currently no clinical approved antiviral drugs and vaccine for coronavirus infections except for supportive treatment [17] . Immunoglobulin may enhance the All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.26.20041426 doi: medRxiv preprint ability of anti-infection in severely ill patient, and steroids are considered in those patients with ARDS. Oxygen inhalation was important to avoid to ARDS for the COVID-19 patients with hypoxemia. In this study, 76.6% patients received oxygen by nasal catheter, and 90% received antiviral therapy, and 38.1% received glucocorticoids. CDC reported that the case-fatality rate (CFR) of COVID-19 the overall case--fatality rate (CFR) of COVID-19 was 2.3% in confirmed cases, and CFR among critical cases may reach 49.0% [11] . Nevertheless, most of patients were still treated in the hospital. Another retrospective study suggest the CFR was about 11% [13] . Statistical analysis of this study found that the CFR was 14.2%, and most of them were over 70 year-old patients accompanying with chronic illness. In the past one month, numerous effective measures, including blocking cities and roads, closing supermarket, monitoring temperature, building a new hospital and setting up medical assistance team, have been carried out to controlling infection source, preventing transmission and reducing death. Until now, there was no new confirmed patients for 13 days,and hospitalized patients decreased sharply. In conclusion, this retrospective study, based on clinical data, revealed that COIVD-19 mainly infected in older people with comorbidities, and may cause acute severe respiratory syndrome.Chest CT was key to screen those suspected patients, and lymphocytopenia and eosnophils declining without leukocytes increasing may be regarded as an novel evidence in the dignosis of COVID-19. The authors have declared that no conflict of interest exists. No funding is provided with this study the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.26.20041426 doi: medRxiv preprint Another hospital was opened and received increasing patients. Chinese healthy commission. The day is Spring Festival. Yichang closed and the traffic was stopped Standard was relaxed to eliminate the suspected cases. Fujian medical team arrived in Yichang. All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is . All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.26.20041426 doi: medRxiv preprint a. Chest CT images on 9 days after symptom onset b. Chest CT images on 19 days after symptom onset c. Chest CT images on 26 days after symptom onset a. Chest CT images on 5 days after symptom onset b. Chest CT images on 14 days after symptom onset All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.26.20041426 doi: medRxiv preprint February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.03.26.20041426 doi: medRxiv preprint Transmission dynamics and evolutionary history of 2019-nCoV Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance A decade after SARS: strategies for controlling emerging coronaviruses Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Epidemiologic characteristics of early cases with 2019 -nCoV disease in Republic of Korea Clinical features of patients infected with 2019 novel coronavirus in Wuhan Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chi nese Center for Disease Control and Prevention The digestive system is a potential route of 2019 -nCov infection: a bioinformatics analysis based on single-cell transcriptomes Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Comparative study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting uncontrolled inflammation might not be the main reason of tissue injury Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan Sensitivity of chest CT for COVID-19: comparison to RT-PCR None.